Ticker Symbol: BBIO
BridgeBio Pharma Inc
$47.25 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0001743881
Company Profile
we focus on accelerating and maximizing value in early-stage, genetic disease assets by applying our management expertise and proprietary platform. our team picks the right assets based on our systematic mapping of the genetic disease landscape, and develops those assets with the right approach, supporting r&d with expert capabilities and placing them in a value maximizing corporate structure.
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: 421 Kipling St
Website: http://bridgebio.com/
CEO: Neil Kumar
Tags:
- Health Technology
- Pharmaceuticals: Generic
- Biotechnology
- Manufacturing
- Pharmaceutical Preparation Manufacturing
Pricing
Last Updated: October 20, 2023 03:00 PM EST
Previous Close: $24.57
Change:
-$0.11
(
-0.45%)
Days Range: $24.42 - $25.25
Beta: 2.07
52wk. High: $36.36
52wk. Low: $6.64
Ytd. Change 221.99%
50 Day Moving Average: $26.91
200 Day Moving Average: $22.25
Shares Outstanding: 162472000
Valuation
Market Cap: 399.2B
PE Ratio: -6.55
EPS (TTM): -3.75
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A